Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat

Molecular and Cellular Neuroscience

Volumn 46, Issue 1, 2011, Pages 333-339

  Edvinsson, Lars ^a   Eftekhari, Sajedeh ^a   Salvatore, Christopher A ^b   Warfvinge, Karin ^a  

^a LUND UNIVERSITY   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CGRP; CLR; Immunohistochemistry; RAMP1; Rat cerebellum

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S 100; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ARTICLE; CONFOCAL MICROSCOPY; DENDRITIC CELL; EPIFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; RAT;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CALCITONIN RECEPTOR-LIKE PROTEIN; CEREBELLUM; HUMANS; MIGRAINE DISORDERS; PURKINJE CELLS; RATS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

RATTUS;

EID: 78650856489     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.10.005     Document Type: Article

References (24)

1. Bahra A., Matharu M.S., Buchel C., Frackowiak R.S., Goadsby P.J. Brainstem activation specific to migraine headache. Lancet 2001, 357:1016-1017.
2. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 2004, 24:611-622.
3. Edvinsson L. CGRP-receptor antagonism in migraine treatment. Lancet 2008, 372:2089-2090.
4. Edvinsson L. CGRP blockers in migraine therapy: where do they act? Br. J. Pharmacol. 2008, 155:967-969.
5. Edvinsson L., Uddman R. Neurobiology in primary headaches. Brain Res. Rev. 2005, 48:438-456.
6. Eftekhari S., Salvatore C., Calamari A., Kane S.A., Tajti J., Edvinsson L. Differential distribution of calcitonin gene-related peptide (CGRP) and CGRP receptor components (CLR and RAMP1) in the human trigeminal ganglion. Neuroscience 2010, 169:683-696.
7. Goadsby P.J., Lipton R.B., Ferrari M.D. Migraine-current understanding and treatment. N Engl J. Med. 2002, 346:257-270.
8. Gregg K.V., Bishop G.A., King J.S. Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex. J. Neurocytol. 1999, 28:431-438.
9. Ho T.W., Ferrari M.D., Dodick D.W., Galet V., Kost J., Fan X., Leibensperger H., Froman S., Assaid C., Lines C., Koppen H., Winner P.K. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 2008, 372:2115-2123.
10. Ho T.W., Mannix L.K., Fan X., Assaid C., Furtek C., Jones C.J., Lines C.R., Rapoport A.M. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008, 70:1304-1312.
11. Ho T.W., Edvinsson L., Goadsby P.J. CGRP and its receptor provide new insights into migraine pathophysiology. Nat. Rev. Neurol. 2010, 6:573-582.
12. Kawai Y., Takami K., Shiosaka S., Emson P.C., Hillyard C.J., Girgis S., MacIntyre I., Tohyama M. Topographic localization of calcitonin gene-related peptide in the rat brain: an immunohistochemical analysis. Neuroscience 1985, 15:747-763.
13. Lee Y., Kawai Y., Shiosaka S., Takami K., Kiyama H., Hillyard C.J., Girgis S., MacIntyre I., Emson P.C., Tohyama M. Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis. Brain Res. 1985, 330:194-196.
14. May A., Goadsby P.J. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cereb. Blood Flow Metab. 1999, 19:115-127.
15. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
16. Morara S., Provini L., Rosina A. CGRP expression in the rat olivocerebellar system during postnatal development. Brain Res. 1989, 504:315-319.
17. Morara S., Rosina A., Provini L., Forloni G., Caretti A., Wimalawansa S.J. Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: an autoradiographic and immunohistochemical analysis. Neuroscience 2000, 100:381-391.
18. Morara S., van der Want J.J., de Weerd H., Provini L., Rosina A. Ultrastructural analysis of climbing fiber-Purkinje cell synaptogenesis in the rat cerebellum. Neuroscience 2001, 108:655-671.
19. Morara S., Wimalawansa S.J., Rosina A. Monoclonal antibodies reveal expression of the CGRP receptor in Purkinje cells, interneurons and astrocytes of rat cerebellar cortex. NeuroReport 1998, 9:3755-3759.
20. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., Lesko L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J. Med. 2004, 350:1104-1110.
21. Oliver K.R., Kane S.A., Salvatore C.A., Mallee J.J., Kinsey A.M., Koblan K.S., Keyvan-Fouladi N., Heavens R.P., Wainwright A., Jacobson M., Dickerson I.M., Hill R.G. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur. J. Neurosci. 2001, 14:618-628.
22. Ueda T., Ugawa S., Saishin Y., Shimada S. Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. Brain Res. Mol. Brain Res. 2001, 93:36-45.
23. Vincent M., Hadjikhani N. The cerebellum and migraine. Headache 2007, 47:820-833.
24. Weiller C., May A., Limmroth V., Juptner M., Kaube H., Schayck R.V., Coenen H.H., Diener H.C. Brain stem activation in spontaneous human migraine attacks. Nat. Med. 1995, 1:658-660.